Evidence against this is provided by the study by Fujita et al. mentioned above, in which 30% of a cohort of 27 patients in the acute phase of rheumatoid arthritis were found to be positive for C. pneumoniae IgM antibodies [1]. The gene discussed is CD40LG; the disease is rheumatoid arthritis.